Ken Fisher
ICPT

Ken Fisher’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Ken Fisher’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-59,970
Closed -$1.48M – 978
2020
Q4 		$1.48M Sell
59,970
-2,873
-5% -$95.2K ﹤0.01% 554
2020
Q3 		$2.6M Sell
62,843
-4,268
-6% -$196K ﹤0.01% 454
2020
Q2 		$3.21M Sell
67,111
-147
-0.2% -$11.4K ﹤0.01% 428
2020
Q1 		$4.24M Sell
67,258
-7,958
-11% -$715K 0.01% 372
2019
Q4 		$9.32M Sell
75,216
-5,386
-7% -$482K 0.01% 349
2019
Q3 		$5.35M Buy
80,602
+493
+0.6% +$33.1K 0.01% 429
2019
Q2 		$6.37M Buy
80,109
+42,099
+111% +$3.77M 0.01% 405
2019
Q1 		$4.25M Buy
38,010
+46
+0.1% +$5.03K 0.01% 435
2018
Q4 		$3.83M Sell
37,964
-511
-1% -$53K 0.01% 444
2018
Q3 		$4.86M Sell
38,475
-6,112
-14% -$647K 0.01% 422
2018
Q2 		$3.74M Buy
44,587
+4,835
+12% +$354K ﹤0.01% 469
2018
Q1 		$2.45M Sell
39,752
-100
-0.3% -$6.03K ﹤0.01% 508
2017
Q4 		$2.33M Buy
39,852
+26,416
+197% +$1.67M ﹤0.01% 508
2017
Q3 		$780K Buy
+13,436
New +$1.45M ﹤0.01% 583

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Ken Fisher's ICPT Position: Q1 2021 in Review

Ken Fisher sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 59,970 shares — an estimated $1.48M sold.

Ken Fisher first reported a position in ICPT in Q3 2017 and held it in 14 quarters. The position peaked at $9.32M in Q4 2019. 151 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

  • Ken Fisher reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Ken Fisher sold 59,970 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $1.48M.
  • Ken Fisher first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 14 quarters.
  • Ken Fisher's Intercept Pharmaceuticals, Inc. position peaked at $9.32M in Q4 2019.
  • 151 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Fisher Asset Management's 13F filing for Q1 2021, filed 27 Apr 2021.